Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI) supports researchers studying diagnostic-guided treatment of resistant infections to assess timeliness and effectiveness.
Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment Options funds researchers’ studies to assess real-world treatment outcomes.
Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections funds independent researchers studying treatment outcomes to improve patient care.
Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment Options supports investigators studying tissue exposure to understand links to treatment outcomes.
Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia supports healthcare teams' local quality improvement projects to improve diagnosis, treatment, and adult care.
Epidemiology & Real-World Evidence of SUL-DUR in Special Populations with CRAB Infection funds researchers studying CRAB and SUL-DUR in adult patient groups in China to assess disease burden and treatment outcomes.